Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Increased Clostridium Difficile Infections Due to Antibiotic Misuse

By LabMedica International staff writers
Posted on 11 Mar 2015
Changes in the epidemiology of Clostridium difficile infections have occurred since the emergence of the North American pulsed-field gel electrophoresis type 1 (NAP1) strain, which has been responsible for geographically dispersed hospital-associated outbreaks.

Clostridium difficile is a bacterium that causes colitis and inflammation of the colon and infection can occur through touching surfaces or items that are contaminated with feces, in which the bacteria are is shed. More...
People who are taking antibiotics for other illnesses are most prone to C. difficile infection as antibiotics can destroy some of the friendly bacteria in the gut, meaning it may be less protected against C. difficile.

A team of investigators led by those at the Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) identified all positive C. difficile test results from 88 inpatient and 33 outpatient laboratories serving residents in surveillance areas in 2011. A case of C. difficile infection was defined as a positive result on a C. difficile toxin or molecular assay of a stool specimen obtained from a surveillance-area resident at least one year of age who had not had a positive assay in the previous eight weeks. Recovered isolates underwent pulsed-field gel electrophoresis (PFGE) and also underwent polymerase-chain-reaction (PCR) assay to detect the presence of particular genes.

A total of 15,461 cases of C. difficile infection were identified in the 10 geographic areas; 65.8% were healthcare associated, but only 24.2% had onset during hospitalization. The North American pulsed-field gel electrophoresis type 1 (NAP1) strain was more prevalent among healthcare-associated infections than among community-associated infections. The study found that individuals aged 65 and older are particularly vulnerable to C. difficile infection. Around one in three cases occurred among patients in this age group, and they also accounted for two in three healthcare-associated C. difficile infections. What is more, around 80% of C. difficile-attributable deaths occurred in patients aged 65 or older.
The team also identified an increased risk of C. difficile infection among women and Caucasian individuals.

The CDC say these results indicate that improved antibiotic use and infection control needs to be put in place for outpatient health care, as well as inpatient facilities. Michael Bell, MD, deputy director of the Division of Healthcare Quality and Promotion at the CDC, said, “Overall, there are two main things that need to be improved. Number one is how antibiotics are being used, making sure that we use them when they're truly necessary and only for as long as necessary. The second element is to ensure rigorous infection control in all health care settings. C. difficile infections must be diagnosed quickly and correctly so that the infected patient can be cared for using the right infection control techniques.” The study was published on February 26, 2015, in the New England Journal of Medicine.

Related Links:

The Centers for Disease Control and Prevention 



New
Gold Member
Collection and Transport System
PurSafe Plus®
Portable Electronic Pipette
Mini 96
New
8-Channel Pipette
SAPPHIRE 20–300 µL
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The study has linked blood proteins to Alzheimer’s disease and memory loss (Photo courtesy of Shutterstock)

Blood Test Could Detect Proteins Linked to Alzheimer's Disease and Memory Loss

Alzheimer’s disease has long been associated with sticky amyloid plaques in the brain, but these markers alone do not fully explain the memory loss and cognitive decline patients experience.... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.